Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:4FR Stock Latest News

Company AnnouncementsFaron reappoints key members to Nomination Board as cancer immunotherapy pipeline advances4w ago

Company AnnouncementsFaron defers EUR 1.4m convertible bond amortisation to bolster funding for cancer immunotherapy1M ago
Company AnnouncementsFaron resets IPF warrant terms as convertible bonds amortised1M ago
RatingsFaron Buy Rating Reiterated as Bexmarilimab Advances to Fully Funded Pivotal Trials; £10 Price Target Maintained2M ago
Company AnnouncementsFaron Pharmaceuticals Sets Date for Half-Year 2026 Financial Results2M ago

Faron Uses Treasury Shares to Settle EUR 1.58m Convertible Bond Amortisation

Company AnnouncementsFaron Uses Treasury Shares to Settle EUR 1.58m Convertible Bond Amortisation3M ago

RatingsPatrick Trucchio Reaffirms Buy on Bexmarilimab, Citing Robust Clinical Data, Valuation Upside and Unchanged £10 Price Target3M ago

Company AnnouncementsFaron posts encouraging survival signal in bexmarilimab HR-MDS trial3M ago

RatingsBexmarilimab Progress and Solid-Tumor Milestones Support Reaffirmed Buy Rating and Unchanged £10 Price Target3M ago
Company AnnouncementsFaron Pharmaceuticals Grants 2.17 Million Share Options Under 2026 Incentive Plan4M ago
RatingsAnalyst Reaffirms Buy on Faron Pharmaceuticals, Maintaining $10 Price Target on Strong Bexmarilimab Data4M ago
Company AnnouncementsFaron Registers New Treasury Shares to Support Potential Bond Conversions4M ago

Faron Pharmaceuticals Fined by Nasdaq Helsinki Over Disclosure Delays

Company AnnouncementsFaron Pharmaceuticals Fined by Nasdaq Helsinki Over Disclosure Delays5M ago

Company AnnouncementsFaron Pharmaceuticals Issues New Shares to Settle Convertible Bond Amortisations5M ago

Company AnnouncementsFaron Pharmaceuticals Issues New Treasury Shares to Prepare for Bond Conversions5M ago

Company AnnouncementsFaron Pharmaceuticals Issues Additional Special Rights Linked to Bond Tranches5M ago
Company AnnouncementsFaron Pharmaceuticals Ends Liquidity Deal as Share Trading Strengthens6M ago
Company AnnouncementsFaron Pharmaceuticals Adds Veteran Biotech Dealmaker Golumbeski to Board6M ago
RatingsAnalyst Reiterates Buy on Faron as Bexmarilimab Advances and Funding Extends Runway; $10 Price Target Maintained6M ago

Faron AGM Backs Equity-Funding Flexibility and New Option Plan Amid Ongoing Losses

Company AnnouncementsFaron AGM Backs Equity-Funding Flexibility and New Option Plan Amid Ongoing Losses6M ago

Company AnnouncementsFaron Resets Warrant Terms and Issues New Equity-Linked Instruments to IPF6M ago

Company AnnouncementsFaron Finalizes Share Offering Registration, Boosting Free Float and Voting Base6M ago